Patent ID: 7482330

Claim:
A method for treating diabetes in a mammal, said method comprising administering to a mammal in need of treatment an effective amount of a compound of formula (IV): wherein: one of the dashed lines between NR 1 and X or between X and Y is present, or both are absent; two of V, M, and W are H and the third is R 1 is H, or C 1-4 alkyl; or, where the dashed line between NR 1 and X is present, R 1 is absent; X is N, C═O, CH, or C-Q-Z; Y is N-Q-Z or C-Q-Z, where X is N, C═O, or CH; Y is CH, where X is C-Q-Z; Q=—(CH 2 ) n — where n=1 or 2; P=H, C 1-7 acyl, or C 1-6 alkoxycarbonyl; Z is substituted or unsubstituted, and is selected from C 3-7 cycloalkyl, phenyl, a 5- or 6-membered heteroaryl having 1 or 2 heteroatoms independently selected from N, O, and S, a biaryl, a 9- or 10-membered fused bicyclyl, and a fused heterobicyclyl, wherein said fused heterobicyclyl has between 1 and 4 heteroatoms independently selected from N, O, and S; or a pharmaceutically acceptable salt thereof.